Back

ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab

European Heart Journal

10 June 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS PREVENTIVE CARDIOLOGY Risk Factors and Prevention

Contributors

Gerald F Watts
Gerald F Watts

Author

University of Western Australia Perth , Australia

Seyed Saeed Tamehri Zadeh
Seyed Saeed Tamehri Zadeh

Author

Dick C Chan
Dick C Chan

Author

You may be interested in
thumbnail
Congress Presentation
RNA-based therapy in dyslipidaemia
27 August 2023
thumbnail
Congress Presentation
Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study
30 August 2020
thumbnail
Congress Presentation
Carotid plaques stabilization and regression with evolocumab
1 September 2025
thumbnail
Congress Presentation
Safety and efficacy of zodasiran, a hepatic sirna targeting angptl3, in mixed hyperlipidemia patients: 2 year open label extension (OLE) results from ARCHES-2
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources